Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80089143
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
-
BERBERINE(2)
;
BERBERINE S5X (tm) ;
BERBERINE TGPS (tm) ;
Berberine Complex ;
Bio-Active Berberine ;
Bio-Berberine ;
METASYN No 1 ;
SYNERGISTIC BERBERINE - Licence holder:
- Provita Nutrition and Health Inc.
- Dosage Form:
- Capsule, delayed-release
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults | 19 | year(s) | 2.0 | capsule | 1 | 2 | daily | |||||
- Recommended use or purpose:
- Provides support for healthy glucose metabolism.
- Risk Information:
- Cautions and Warnings
- If you have hypoglycemia, hypotension or if you take medicines for diabetes, consult a health care practitioner prior to use. If you have leukopenia, consult a health care practitioner prior to use. f you have cardiovascular disease, a liver or kidney disorder or diabetes, consult a health care practitioner prior to use.
- Contra-Indications
- Do not use if you are pregnant or breastfeeding. If you have an allergy to seafood, do not use this product.
- Known Adverse Reactions
- May cause gastrointestinal discomfort such as constipation, vomiting, abdominal pain or diarrhea, in which case discontinue use and consult a health care practitioner.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium |
250.0 mg
|
||
Chromium |
10.0 mcg
|
||
Poly-beta-(1,4)-2-amino-2-deoxy-d-glucose |
16.6 mg
|
- List of non-medicinal ingredients:
-
- Caprylic acid
- Gellan gum
- Hypromellose
- Microcrystalline cellulose
- Quillaja extract
- Sodium hydroxide
- Tocofersolan
- Date of licensing:
- 2018-11-09
- Revised date of licence:
- 2024-11-19
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).